Description
The marker is associated with changes in bilirubin metabolism levels. It is investigated to detect genetic predisposition to the development of Gilbert's syndrome, neonatal hyperbilirubinemia, and Crigler-Najjar syndrome. It is informative for evaluating the effectiveness of treatment with Irinotecan (Irinotel, Iriten, Irnocam, Camptera, Campto). OMIM: 191740.
Period of execution
Within 9 days
Biomaterial type